If reticulocytes have not increased after treatment or if reticulocyte counts do not continue at least twice normal as long as the hematocrit is less than 35%, diagnosis or treatment should be reevaluated
Injection site management Given the elevated injection site reaction rates with cagrilintide, proactive management is especially important: Rotate injection sites systematically using a rotation schedule (abdomen, right thigh, left thigh, right arm, left arm) Allow the solution to reach room temperature before injecting Inject slowly over 5 to 10 seconds rather than quickly Apply ice before injection to reduce pain Do not massage the injection site afterward Use proper technique as outlined in our peptide injection guide Keeping a log of injection sites and reactions helps identify whether certain areas are more problematic than others
Then they will pass a long, thin, flexible tube with a camera and a light at the tip, down your throat, through your esophagus, into your stomach and the first part of your small intestine (the duodenum)
our team stays current with available preparations and will advise on what is accessible and evidence-supported for your case
